2016
DOI: 10.1016/j.ijrobp.2016.06.1108
|View full text |Cite
|
Sign up to set email alerts
|

Adaptive MR-Guided Stereotactic Body Radiation Therapy (AMR-SBRT) for Oligometastatic or Unresectable Primary Abdominal Malignancies: Results of a Prospective Phase I Trial

Abstract: Purpose/Objective(s): Stereotactic body radiation therapy (SBRT) has emerged as an effective treatment modality for locally advanced pancreatic cancer. However, success can be dependent on the definition of local progression (LP). Evaluation of local tumor response has typically been defined by computed tomography (CT) imaging, which is often subject to post-radiation inflammatory changes that limit response assessment. The purpose of this study is to determine the benefit of adding 18 F-fluorodeoxyglucose-pos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…Visual biofeedback based on direct tumor visualization was applied in our adaptive radiotherapy workflow 15,19 . The adaptive treatment planning and delivery workflows have been discussed in previous reports 15,16 .…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Visual biofeedback based on direct tumor visualization was applied in our adaptive radiotherapy workflow 15,19 . The adaptive treatment planning and delivery workflows have been discussed in previous reports 15,16 .…”
Section: Methodsmentioning
confidence: 99%
“…Visual biofeedback based on direct tumor visualization was applied in our adaptive radiotherapy workflow. 15,19 The adaptive treatment planning and delivery workflows have been discussed in previous reports. 15,16 The additional workflow specific to providing direct tumor visualization to the patient is described below.…”
Section: C | Clinical Workflow Of Direct Tumor Visualizationmentioning
confidence: 99%
“…Magnetic resonance guided radiotherapy (MRgRT) has become an important treatment modality for improving treatment outcomes by increasing local control rates and reducing normal tissue toxicity. 1 , 2 , 3 Systems that combine a magnetic resonance imaging (MRI) scanner and a linear accelerator (Linac) provide beam gating, real‐time target tracking, and the ability to perform online adaptive radiotherapy. 3 , 4 , 5 Additionally, soft tissue contrast and structure identification with on‐board MRI systems are superior to that provided by on‐board X‐ray systems, both for 2D planar images and volumetric images such as cone beam CT (CBCT), without the addition of any excess ionizing radiation.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, MRgRT with real-time two-dimensional (2D) tumor tracking is clinically available 5,6 and MRgRT treatments have been demonstrated to produce excellent local control rates with little toxicity. 5,7,8 Tumors benefiting most from real-time 2D tumor tracking are those near the diaphragm where organs experience the maximal respiratory motion, including the lower lobe of the lungs and the liver dome.…”
Section: Introductionmentioning
confidence: 99%
“…Magnetic Resonance‐guided radiotherapy (MRgRT) is a highly desirable image‐guided radiotherapy (IGRT) modality for moving targets because it provides continuous imaging of patient anatomy with the superior soft tissue contrast provided by MRI, without the ionizing radiation imparted by x‐ray imaging, during radiation beam delivery. Currently, MRgRT with real‐time two‐dimensional (2D) tumor tracking is clinically available 5,6 and MRgRT treatments have been demonstrated to produce excellent local control rates with little toxicity 5,7,8 . Tumors benefiting most from real‐time 2D tumor tracking are those near the diaphragm where organs experience the maximal respiratory motion, including the lower lobe of the lungs and the liver dome.…”
Section: Introductionmentioning
confidence: 99%